Medical University of South Carolina South Carolina Population Genomics Program Marks First Anniversary With Surge in Participation Premium The In Our DNA SC partnership between MUSC and Helix is still struggling to match the diversity of the South Carolina population, but outreach is expanding. Helix, Medical University of South Carolina Partner for Population Genomics Program The effort plans to enroll 100,000 patients and return genetic findings in order to drive personalized and proactive care and to grow a clinico-genomic database. Human Microbiome Program at MUSC Shows Early Promise Premium Two years in, the MUSC Program for Human Microbiome Research is finding its footing, but it has high ambitions for creating safer care environments. MUSC Wins NIH Grant to Support Proteogenomics, Bioinformatics Core The grant will help create the new core as part of the existing South Carolina Center of Biomedical Research Excellence (COBRE) for cardiovascular disease. Emory Wins Funding for TBI Biomarker Study The researchers will use an NIH grant to seek protein biomarkers in the blood to predict clinical outcomes of traumatic brain injury. Jul 19, 2011 IP Watch: Recent Patents Related to PCR, Nucleic Acid Amplification, and Sample Prep: Jul 19, 2011 Premium Mar 25, 2009 People Transfer: Mar 25, 2009 Premium Mar 5, 2009 NHLBI Set to Start Third Major Proteomics Program Premium Breaking News MDxHealth, University of Oxford to Assess Prostate Test for Predicting Localized Treatment Outcomes Eagle Genomics Raises £3M in Add-On Financing Golden Helix Wins $400K SBIR Grant to Integrate Pharmacogenetics Analytics Into Genetic Testing SARS-CoV-2 Mutational Signature Associated With Mutagenic Antiviral Drug Biocartis Restructures Balance Sheet as H1 2023 Revenues Rise 12 Percent The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.